| scholarly article | Q13442814 |
| P50 | author | Maria Tereza Nunes | Q106786137 |
| P2093 | author name string | Roberto B Bazotte | |
| Ana C Panveloski-Costa | |||
| Silvania da Silva Teixeira | |||
| Raquel S Campello | |||
| Aline Carvalho | |||
| Any de Castro Ruiz Marque | |||
| Fabiana P Monteiro Schiavon | |||
| P2860 | cites work | Role of Insulin in the Hepatic Handling of Glucose | Q39977726 |
| Thyroid hormone reduces inflammatory cytokines improving glycaemia control in alloxan-induced diabetic wistar rats | Q40125711 | ||
| Control of glycaemia | Q40850456 | ||
| Incidence and prevalence of thyroid dysfunction in type 1 diabetes | Q40914809 | ||
| Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling | Q42032355 | ||
| Triiodothyronine increases glucose transporter isotype 4 mRNA expression, glucose transport, and glycogen synthesis in adult rat cardiomyocytes in long-term culture | Q42517571 | ||
| T(3) increases mitochondrial ATP production in oxidative muscle despite increased expression of UCP2 and -3. | Q43565238 | ||
| Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models | Q46516165 | ||
| Effect of feeding, fasting, and diabetes on liver glycogen synthase activity, protein, and mRNA in rats. | Q51574678 | ||
| Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. | Q51621447 | ||
| Differential effect of hyperglycemia and hyperinsulinemia on pathways of hepatic glycogen repletion | Q70160550 | ||
| Thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle. The role of GLUT4 glucose transporter expression | Q72717659 | ||
| LIVER GLYCOGEN SYNTHESIS IN INTACT ALLOXAN DIABETIC RATS | Q76613879 | ||
| T3 rapidly increases SLC2A4 gene expression and GLUT4 trafficking to the plasma membrane in skeletal muscle of rat and improves glucose homeostasis | Q82779415 | ||
| Intensive insulin treatment induces insulin resistance in diabetic rats by impairing glucose metabolism-related mechanisms in muscle and liver | Q84539920 | ||
| Inhibitory effect of tumor necrosis factor α on gluconeogenesis in perfused rat liver | Q85639235 | ||
| Tumor necrosis factor alpha abolished the suppressive effect of insulin on hepatic glucose production and glycogenolysis stimulated by cAMP | Q88032164 | ||
| Endotoxin induced hyperlactatemia and hypoglycemia is linked to decreased mitochondrial phosphoenolpyruvate carboxykinase | Q28567552 | ||
| Monochloroacetic acid inhibits liver gluconeogenesis by inactivating glyceraldehyde-3-phosphate dehydrogenase | Q28580148 | ||
| New insights into the role and mechanism of glycogen synthase activation by insulin | Q30470182 | ||
| Action of thyroid hormones at the cellular level: the mitochondrial target. | Q33674164 | ||
| SGLT2 inhibition--a novel strategy for diabetes treatment | Q34117872 | ||
| Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications | Q34120717 | ||
| Thyroid hormone excess and glucose intolerance | Q34312047 | ||
| Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models | Q34514818 | ||
| Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes | Q34583551 | ||
| FoxO proteins in insulin action and metabolism | Q36110215 | ||
| Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes | Q37148316 | ||
| Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans | Q37379144 | ||
| Excess thyroid hormone and carbohydrate metabolism | Q37443390 | ||
| Central and peripheral effects of thyroid hormone signalling in the control of energy metabolism | Q37632562 | ||
| Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target. | Q37645623 | ||
| Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes. | Q38323028 | ||
| Empagliflozin, an SGLT2 inhibitor for the treatment of type 2 diabetes mellitus: a review of the evidence | Q38364908 | ||
| P433 | issue | 18 | |
| P921 | main subject | glucose | Q37525 |
| glycobiology | Q899224 | ||
| P577 | publication date | 2016-09-01 | |
| P1433 | published in | Physiological Reports | Q15716763 |
| P1476 | title | Thyroid hormone treatment decreases hepatic glucose production and renal reabsorption of glucose in alloxan-induced diabetic Wistar rats | |
| P478 | volume | 4 |
| Q58103815 | Basal glucosuria in cats |
| Q49502882 | Beneficial effects of thyroid hormone on adipose inflammation and insulin sensitivity of obese Wistar rats |
| Q94596444 | Effect of Insulin on Proximal Tubules Handling of Glucose: A Systematic Review |
| Q48112061 | Reduced blood glucose through thyroid hormone degradation product |
Search more.